XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Net sales $ 1,339 $ 1,764 $ 3,324 $ 5,305
Cost of sales 1,387 1,927 3,176 5,385
Gross (loss) profit (48) (163) 148 (80)
Operating expenses:        
Product development 142 366 443 1,222
Selling, general, and administrative 713 1,802 2,911 5,893
Loss on write-off of fixed assets 0 76 0 76
Total operating expenses 855 2,244 3,354 7,191
Loss from operations (903) (2,407) (3,206) (7,271)
Other expenses (income):        
Interest expense, net 34 235 226 679
Other income 0 0 (16) (30)
Other expenses 7 20 28 49
Net loss $ (944) $ (2,662) $ (3,444) $ (7,969)
Net loss per common share - basic and diluted        
Net loss, basic (USD per share) $ (0.27) $ (2.03) $ (1.20) $ (7.33)
Net loss, diluted (USD per share) $ (0.27) $ (2.03) $ (1.20) $ (7.33)
Weighted average shares of common stock outstanding:        
Basic (in shares) [1] 3,514 1,313 2,868 1,087
Diluted (in shares) [1] 3,514 1,313 2,868 1,087
[1] * Shares outstanding for prior periods have been restated for the 1-for-7 reverse stock split effective June 16, 2023.